Trial results investigating the molecular mechanisms of exercise benefits for insulin resistant people with obesity were posted on ClinicalTrials.gov on 2025-11-25, with 58 participants enrolled.
Background
Obesity is a complex chronic disease characterized by excessive body fat, often leading to various health complications including insulin resistance. Insulin resistance, a condition where the body's cells don't respond effectively to insulin, can precede type 2 diabetes and is a significant public health concern. Exercise, particularly resistance training, is a well-established intervention for managing both obesity and insulin resistance, known to improve metabolic health and body composition. Understanding the specific benefits and underlying mechanisms of exercise is crucial for optimizing treatment strategies.
Trial design
This completed study, designated as Phase NA, enrolled 58 participants to investigate conditions including Insulin Resistance and Obesity. The trial aimed to explore the molecular mechanisms by which resistance exercise training benefits insulin-resistant individuals. Participants were divided into an Insulin Resistant Exercise Group and an Insulin Resistant Control Group to assess changes in various physiological parameters.
Key results
The trial reported several key measurements comparing the exercise and control groups:
- Change in Muscle Strength (Ratio):
- Insulin Resistant Exercise Group: Mean of 0.37 (Standard Deviation 0.31).
- Insulin Resistant Control Group: Mean of -0.2 (Standard Deviation 0.32).
- Change in Insulin Sensitivity (μIU*min/mL):
- Insulin Resistant Exercise Group: Mean of -743.7 (Standard Deviation 2292).
- Insulin Resistant Control Group: Mean of -105.7 (Standard Deviation 2015).
- Change in Lean Mass (grams):
- Insulin Resistant Exercise Group: Mean of 542 (Standard Deviation 1526).
- Insulin Resistant Control Group: Mean of -377 (Standard Deviation 1348).
- Change in Fat Percentage (Percentage):
- Insulin Resistant Exercise Group: Mean of -0.89 (Standard Deviation 1.01).
- Insulin Resistant Control Group: Mean of 0.12 (Standard Deviation 1.14).
What this means
The results indicate that resistance exercise training may lead to beneficial changes in body composition and muscle function for individuals with obesity and insulin resistance. The Insulin Resistant Exercise Group demonstrated an increase in muscle strength and lean mass, alongside a reduction in fat percentage, contrasting with the control group which generally showed declines or smaller changes in these metrics. While the mean change in insulin sensitivity was larger in the exercise group, the wide dispersion values suggest individual variability. These findings support the role of exercise as a beneficial intervention for improving physical health parameters in this population.
Source
The information for these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04158375, titled "Molecular Mechanisms of Exercise Benefits to Insulin Resistant People", were posted on 2025-11-25 on clinicaltrials.gov.
